GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,231,786,000 | -13.5% | 74,242,722 | -13.4% | 2.24% | -1.5% |
| Q1 2022 | $3,735,297,000 | -4.3% | 85,750,621 | -3.1% | 2.27% | -6.1% |
| Q4 2021 | $3,903,707,000 | +16.1% | 88,519,444 | +0.6% | 2.42% | +10.4% |
| Q3 2021 | $3,363,164,000 | -4.3% | 88,017,914 | -0.2% | 2.19% | -4.7% |
| Q2 2021 | $3,512,490,000 | +11.9% | 88,209,189 | +0.3% | 2.30% | +2.4% |
| Q1 2021 | $3,138,837,000 | +35.5% | 87,947,245 | +39.7% | 2.24% | +22.6% |
| Q4 2020 | $2,316,036,000 | +36.7% | 62,935,758 | +39.9% | 1.83% | +18.1% |
| Q3 2020 | $1,693,825,000 | +0.0% | 45,000,656 | +8.4% | 1.55% | -0.5% |
| Q2 2020 | $1,693,713,000 | +1.5% | 41,522,745 | -5.7% | 1.56% | -13.7% |
| Q1 2020 | $1,668,512,000 | -23.5% | 44,035,690 | -5.1% | 1.80% | +8.2% |
| Q4 2019 | $2,179,782,000 | +5.7% | 46,388,219 | -4.0% | 1.67% | -1.7% |
| Q3 2019 | $2,062,912,000 | +6.9% | 48,334,394 | +0.2% | 1.70% | +8.7% |
| Q2 2019 | $1,930,285,000 | -3.9% | 48,233,018 | +0.3% | 1.56% | -5.3% |
| Q1 2019 | $2,009,344,000 | +9.6% | 48,081,945 | +0.2% | 1.65% | -1.8% |
| Q4 2018 | $1,833,564,000 | -4.9% | 47,986,487 | -0.0% | 1.68% | +13.9% |
| Q3 2018 | $1,928,350,000 | -0.7% | 48,004,737 | -0.3% | 1.48% | -4.9% |
| Q2 2018 | $1,941,263,000 | +2.3% | 48,158,337 | -0.8% | 1.55% | +1.3% |
| Q1 2018 | $1,896,925,000 | +21.3% | 48,551,967 | +10.1% | 1.53% | +26.4% |
| Q4 2017 | $1,563,634,000 | +159.2% | 44,083,293 | +196.7% | 1.21% | +149.7% |
| Q3 2017 | $603,240,000 | +47028.1% | 14,858,137 | +49949.3% | 0.48% | +48400.0% |
| Q2 2017 | $1,280,000 | -5.7% | 29,687 | -7.8% | 0.00% | 0.0% |
| Q1 2017 | $1,357,000 | -4.2% | 32,187 | -12.4% | 0.00% | 0.0% |
| Q4 2016 | $1,416,000 | -21.8% | 36,762 | -12.4% | 0.00% | -50.0% |
| Q3 2016 | $1,810,000 | -5.6% | 41,962 | -5.2% | 0.00% | 0.0% |
| Q2 2016 | $1,918,000 | -41.8% | 44,262 | -45.5% | 0.00% | -33.3% |
| Q1 2016 | $3,295,000 | -27.6% | 81,262 | -27.9% | 0.00% | -25.0% |
| Q4 2015 | $4,551,000 | -41.7% | 112,782 | -44.4% | 0.00% | -50.0% |
| Q3 2015 | $7,802,000 | -98.5% | 202,915 | -98.4% | 0.01% | -98.3% |
| Q2 2015 | $519,667,000 | -52.0% | 12,476,998 | -46.8% | 0.47% | -53.0% |
| Q1 2015 | $1,081,597,000 | +5.6% | 23,436,551 | -2.2% | 1.00% | +4.8% |
| Q4 2014 | $1,024,021,000 | -42.3% | 23,959,301 | -37.9% | 0.95% | -44.0% |
| Q3 2014 | $1,773,944,000 | -44.9% | 38,589,161 | -35.9% | 1.70% | -44.7% |
| Q2 2014 | $3,220,889,000 | -0.2% | 60,226,050 | -0.3% | 3.07% | -6.9% |
| Q1 2014 | $3,226,453,000 | -0.1% | 60,386,550 | -0.2% | 3.30% | -2.0% |
| Q4 2013 | $3,229,009,000 | +5.0% | 60,479,650 | -1.3% | 3.37% | -3.6% |
| Q3 2013 | $3,074,949,000 | -0.6% | 61,290,600 | -1.0% | 3.49% | -5.0% |
| Q2 2013 | $3,094,940,000 | – | 61,935,959 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |